Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Bought by Public Sector Pension Investment Board

Key Points

• The Public Sector Pension Investment Board has increased its stake in Prestige Consumer Healthcare Inc. by 44.6%, bringing its total shares to 178,019, valued at approximately $15.3 million.
• Most analysts currently rate Prestige Consumer Healthcare with a consensus of "Hold," with a recent price target range from $100.00 to $93.33.
• For the last quarter, the company reported earnings per share of $0.95, below the expected $1.01, with a year-over-year revenue decline of 6.6%.

Public Sector Pension Investment Board grew its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 44.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 178,019 shares of the company's stock after buying an additional 54,926 shares during the period. Public Sector Pension Investment Board owned 0.36% of Prestige Consumer Healthcare worth $15,304,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of PBH. Franklin Resources Inc. raised its position in Prestige Consumer Healthcare by 0.7% in the 4th quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock valued at $1,697,000 after purchasing an additional 150 shares during the last quarter. Wells Fargo & Company MN raised its position in Prestige Consumer Healthcare by 103.0% during the 4th quarter. Wells Fargo & Company MN now owns 199,449 shares of the company's stock worth $15,575,000 after buying an additional 101,179 shares during the last quarter. Envestnet Asset Management Inc. raised its position in Prestige Consumer Healthcare by 124.4% during the 4th quarter. Envestnet Asset Management Inc. now owns 169,926 shares of the company's stock worth $13,270,000 after buying an additional 94,192 shares during the last quarter. Bank of Montreal Can raised its position in Prestige Consumer Healthcare by 15.1% during the 4th quarter. Bank of Montreal Can now owns 7,127 shares of the company's stock worth $557,000 after buying an additional 937 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new position in Prestige Consumer Healthcare during the 4th quarter worth $42,593,000. Institutional investors and hedge funds own 99.95% of the company's stock.

Prestige Consumer Healthcare Trading Up 0.7%

NYSE PBH traded up $0.46 during mid-day trading on Friday, hitting $65.06. The company's stock had a trading volume of 698,764 shares, compared to its average volume of 512,360. Prestige Consumer Healthcare Inc. has a 52-week low of $62.95 and a 52-week high of $90.04. The stock's fifty day simple moving average is $77.27 and its two-hundred day simple moving average is $81.58. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99. The firm has a market capitalization of $3.20 billion, a P/E ratio of 15.27, a price-to-earnings-growth ratio of 2.04 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing the consensus estimate of $1.01 by ($0.06). Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The business had revenue of $249.53 million during the quarter, compared to analysts' expectations of $260.71 million. During the same quarter in the previous year, the business posted $0.90 EPS. The company's quarterly revenue was down 6.6% on a year-over-year basis. Research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Analyst Ratings Changes

PBH has been the subject of a number of analyst reports. Canaccord Genuity Group cut their price objective on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating for the company in a research report on Friday, August 8th. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Finally, Wall Street Zen cut shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.